VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $2,290,000 | +46.5% | 98,323 | 0.0% | 0.03% | +45.0% |
Q1 2018 | $1,563,000 | -24.2% | 98,323 | -0.6% | 0.02% | -23.1% |
Q4 2017 | $2,061,000 | +45.3% | 98,923 | 0.0% | 0.03% | +36.8% |
Q3 2017 | $1,418,000 | -17.0% | 98,923 | +0.6% | 0.02% | -20.8% |
Q2 2017 | $1,709,000 | +57.7% | 98,323 | 0.0% | 0.02% | +50.0% |
Q1 2017 | $1,084,000 | -42.7% | 98,323 | +1.1% | 0.02% | -44.8% |
Q4 2016 | $1,892,000 | -20.6% | 97,223 | 0.0% | 0.03% | -25.6% |
Q3 2016 | $2,384,000 | +22.2% | 97,223 | 0.0% | 0.04% | +18.2% |
Q2 2016 | $1,951,000 | -41.1% | 97,223 | 0.0% | 0.03% | -41.1% |
Q1 2016 | $3,310,000 | -66.5% | 97,223 | 0.0% | 0.06% | -67.4% |
Q4 2015 | $9,883,000 | -41.5% | 97,223 | +2.3% | 0.17% | -45.7% |
Q3 2015 | $16,890,000 | -33.7% | 94,993 | +3.5% | 0.32% | -28.4% |
Q2 2015 | $25,461,000 | +40.9% | 91,763 | +0.2% | 0.44% | +37.6% |
Q1 2015 | $18,075,000 | +18.8% | 91,583 | +0.1% | 0.32% | +19.3% |
Q4 2014 | $15,213,000 | +3.2% | 91,463 | +2.1% | 0.27% | -1.1% |
Q3 2014 | $14,736,000 | +15.7% | 89,587 | +1.3% | 0.27% | +16.2% |
Q2 2014 | $12,731,000 | -0.4% | 88,454 | +0.7% | 0.24% | -5.6% |
Q1 2014 | $12,777,000 | +16.7% | 87,854 | 0.0% | 0.25% | +14.2% |
Q4 2013 | $10,948,000 | – | 87,854 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
Hound Partners | 3,898,648 | $695,441,000 | 15.04% |